ID.1
Item
locally advanced or metastatic nsclc
boolean
ID.2
Item
egfr mutation (l858r and /or ex19del)
boolean
ID.3
Item
cmet amplification by fish (gcn ≥ 6),
boolean
ID.4
Item
acquired resistance to egfr tki (1st or 2nd génération)
boolean
ID.5
Item
ecog performance status (ps) ≤ 1.
boolean
ID.6
Item
prior treatment with 3rd generation tki
boolean
ID.7
Item
phaseii : prior treatment with any of the following agents:
boolean
ID.8
Item
crizotinib, or any other cmet inhibitor or hgf-targeting inhibitor.
boolean
ID.9
Item
concomitant egfr tki and platinum based chemotherapy as first line regimen.
boolean
ID.10
Item
platinum-based chemotherapy as first line treatment
boolean